| CTRI Number |
CTRI/2025/09/094944 [Registered on: 16/09/2025] Trial Registered Prospectively |
| Last Modified On: |
16/09/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Ayurveda |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
Effect of ayurvedic panchakarma (Trivrutta avaleha virechana) and Putranjivak seed powder on low sperm count (oligospermia): A clinical study |
|
Scientific Title of Study
|
A Randomized Open Controlled Clinical trial to evaluate the efficacy of trivrutta avaleha virechana followed by Putranjivak beeja churna in ksheena shukra w.s.r. (oligozoospermia) |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Bhushan Appasheb Kale |
| Designation |
PhD Scholar |
| Affiliation |
Department of PG studies in Prasuti tnatra and striroga, Yashwant Ayurvedic College A/p. Kodoli |
| Address |
Department of PG studies in Prasuti tnatra and striroga,Room No. 3, Yashwant Ayurvedic College A/p. Kodoli,Tal-Panhala, Kolhapur Department of PG studies in Prasuti tnatra and striroga,Room No. 3, Yashwant Ayurvedic College A/p. Kodoli,Tal-Panhala, Kolhapur Kolhapur MAHARASHTRA 416114 India |
| Phone |
9175113314 |
| Fax |
|
| Email |
vaidyabhushankale@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Vishal Turlapati |
| Designation |
HOD |
| Affiliation |
Department of PG studies in Prasuti tnatra and striroga, Yashwant Ayurvedic College A/p. Kodoli |
| Address |
Department of PG studies in Prasuti tnatra and striroga,Room No. 3, Yashwant Ayurvedic College A/p. Kodoli,Tal-Panhala, Kolhapur Department of PG studies in Prasuti tnatra and striroga, Room No.3, Yashwant Ayurvedic College A/p. Kodoli,Tal-Panhala, Kolhapur Kolhapur MAHARASHTRA 416114 India |
| Phone |
9960217429 |
| Fax |
|
| Email |
vishalaturlapati@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Bhushan Appasheb Kale |
| Designation |
PhD Scholar |
| Affiliation |
Department of PG studies in Prasuti tnatra and striroga, Yashwant Ayurvedic College A/p. Kodoli |
| Address |
Department of PG studies in Prasuti tnatra and striroga, Room No.3, Yashwant Ayurvedic College A/p. Kodoli,Tal-Panhala, Kolhapur Department of PG studies in Prasuti tnatra and striroga, Room No. 3, Yashwant Ayurvedic College A/p. Kodoli,Tal-Panhala, Kolhapur Kolhapur MAHARASHTRA 416143 India |
| Phone |
9175113314 |
| Fax |
|
| Email |
vaidyabhushankale@gmail.com |
|
|
Source of Monetary or Material Support
|
| Yashwant Ayurvedic College Kodoli, Kolhapur, Maharashtra, India.416114 |
|
|
Primary Sponsor
|
| Name |
Bhushan Appasaheb Kale |
| Address |
Yashwant Ayurvedic College Kodoli, Kolhapur, Maharashtra, India.416114. |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Bhushan Kale |
Yashwant Ayurvedic College Kodoli |
Research advisory commttee Yashwant Ayurvedic College, post graduate training and research centre, Kodoli,Maharashtra, India. 416114 Kolhapur MAHARASHTRA |
9113314175
vaidyabhushankale@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| YASHWANT AYURVEDIC COLLEGE POST GRADUATE TRAINING AND RESEARCH CENTRE KODOLI RESEARCH ADVISORY COMMITTEE |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:N461||Oligospermia. Ayurveda Condition: VANDHYA, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Drug | Classical | | (1) Medicine Name: Putranjivak beeja Churna, Reference: Bhavaprakash, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 90 Days, anupAna/sahapAna: Yes(details: -ushnajala), Additional Information: - | | 2 | Comparator Arm | Drug | Classical | | (1) Medicine Name: Ashvatha Phala churna, Reference: Sushruta samhita chikitsa sthan, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 90 Days, anupAna/sahapAna: Yes(details: -ushnajala), Additional Information: - |
|
|
|
Inclusion Criteria
|
| Age From |
20.00 Year(s) |
| Age To |
50.00 Year(s) |
| Gender |
Male |
| Details |
Male patients aged between 20 and 50 years.
Diagnosed case of Oligozoospermia
Sperm count less than 15 million/ml
Male patients who have signed for consent form
Male patients fit for virechana karma. |
|
| ExclusionCriteria |
| Details |
Azoospermia.
Congenital disorders related to reproductive system like bilateral absence of the vas deferens, cryptorchidism, marfans syndrome, Klinefelter’s syndrome. |
|
|
Method of Generating Random Sequence
|
Coin toss, Lottery, toss of dice, shuffling cards etc |
|
Method of Concealment
|
Case Record Numbers |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To evaluate the efficacy of trivrutta avaleha virechana followed by putranjivak beeja churna in ksheena shukra w.s.r. (oligozoospermia) |
90 days |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| To compare the effect of trivrutta leha virechana followed by Putranjivak beeja churna over ashwatha phala churna in ksheena shukra (oligozoospermia) |
90 days |
| To observe the efficacy of trivrutta leha virechana followed by Putranjivak beeja churna in ksheena shukra w.s.r. (oligozoospermia) |
90 days |
| To achieve improvement in sperm count when given for 90 days. |
90 days |
|
|
Target Sample Size
|
Total Sample Size="68" Sample Size from India="68"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
11/10/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Oligozoospermia, or low sperm count, is a major contributing factor in male infertility and poses significant challenges to conception. Modern treatment options often involve costly, invasive, or temporary measures with limited holistic benefits. Ayurveda describes Ksheena Shukra as a condition comparable to oligozoospermia, caused by depletion or vitiation of Shukra Dhatu, and prescribes both Shodhana (purification) and Shamana (pacifying) therapies for its management. This clinical trial is designed as a Randomized Open Controlled study to evaluate the efficacy of Trivrutta Avaleha Virechana (therapeutic purgation) followed by Putranjivak Beeja Churna (herbal seed powder) in patients with Ksheena Shukra (oligozoospermia). Virechana with Trivrutta Avaleha aims to eliminate accumulated doshas and enhance Agni and dhatu metabolism, thereby creating a favorable milieu for Shukra dhatu formation. Subsequent administration of Putranjivak Beeja Churna, known for its Vrushya (aphrodisiac), Balya (strength-promoting), and Garbhasthapaka (pro-natal) properties, is expected to nourish and restore Shukra Dhatu. The study seeks to assess improvements in sperm count along with clinical outcomes. The results are anticipated to provide scientific validation for classical Ayurvedic therapies and establish an evidence-based, cost-effective, and non-invasive alternative for managing male infertility due to oligozoospermia. |